Physiology and pathophysiology of human airway mucus
The mucus clearance system is the dominant mechanical host defense system of the human
lung. Mucus is cleared from the lung by cilia and airflow, including both two-phase gas-liquid …
lung. Mucus is cleared from the lung by cilia and airflow, including both two-phase gas-liquid …
Cilia dysfunction in lung disease
AE Tilley, MS Walters, R Shaykhiev… - Annual review of …, 2015 - annualreviews.org
A characteristic feature of the human airway epithelium is the presence of ciliated cells
bearing motile cilia, specialized cell surface projections containing axonemes composed of …
bearing motile cilia, specialized cell surface projections containing axonemes composed of …
The bronchiectasis severity index. An international derivation and validation study
JD Chalmers, P Goeminne, S Aliberti… - American journal of …, 2014 - atsjournals.org
Rationale: There are no risk stratification tools for morbidity and mortality in bronchiectasis.
Identifying patients at risk of exacerbations, hospital admissions, and mortality is vital for …
Identifying patients at risk of exacerbations, hospital admissions, and mortality is vital for …
Adult patients with bronchiectasis: a first look at the US bronchiectasis research registry
TR Aksamit, AE O'Donnell, A Barker, KN Olivier… - Chest, 2017 - Elsevier
Objectives We sought to describe the characteristics of adult patients with bronchiectasis
enrolled in the US Bronchiectasis Research Registry (BRR). Methods The BRR is a …
enrolled in the US Bronchiectasis Research Registry (BRR). Methods The BRR is a …
Co‐morbidities in severe asthma: C linical impact and management
C Porsbjerg, A Menzies‐Gow - Respirology, 2017 - Wiley Online Library
Patients with severe asthma represent a minority of the total asthma population, but carry a
majority of the morbidity and healthcare costs. Achieving better asthma control in this group …
majority of the morbidity and healthcare costs. Achieving better asthma control in this group …
The independent contribution of Pseudomonas aeruginosa infection to long-term clinical outcomes in bronchiectasis
D Araújo, M Shteinberg, S Aliberti… - European …, 2018 - Eur Respiratory Soc
Pseudomonas aeruginosa is responsible for chronic infection in many bronchiectasis
patients but it is not known whether it is associated with worse clinical outcomes …
patients but it is not known whether it is associated with worse clinical outcomes …
Airway mucus in pulmonary diseases: Muco-adhesive and muco-penetrating particles to overcome the airway mucus barriers
Airway mucus is a complex viscoelastic gel that provides a defensive physical barrier and
shields the airway epithelium by trapping inhaled foreign pathogens and facilitating their …
shields the airway epithelium by trapping inhaled foreign pathogens and facilitating their …
Airway clearance techniques for bronchiectasis
Background People with non‐cystic fibrosis bronchiectasis commonly experience chronic
cough and sputum production, features that may be associated with progressive decline in …
cough and sputum production, features that may be associated with progressive decline in …
[HTML][HTML] Bacterial community interactions during chronic respiratory disease
AL Welp, JM Bomberger - Frontiers in cellular and infection …, 2020 - frontiersin.org
Chronic respiratory diseases including chronic rhinosinusitis, otitis media, asthma, cystic
fibrosis, non-CF bronchiectasis, and chronic obstructive pulmonary disease are a major …
fibrosis, non-CF bronchiectasis, and chronic obstructive pulmonary disease are a major …
The EMBARC European Bronchiectasis Registry: protocol for an international observational study
Bronchiectasis is one of the most neglected diseases in respiratory medicine. There are no
approved therapies and few large-scale, representative epidemiological studies. The …
approved therapies and few large-scale, representative epidemiological studies. The …